This study was initiated by the French Federation of Homecare Providers (FEDEPSAD). AGIR à dom is involved in this study along with other national service providers.

Obstructive Sleep Apnoea Hypopnoea Syndrome (OSAHS) is characterised by the occurrence of abnormally frequent episodes of interrupted ventilation (apnoeas) or significant reductions in ventilation (hypopnoeas) during sleep. Continuous Positive Airway Pressure (CPAP) is the reference treatment for severe forms of OSAHS.

Since January 2018, 80% of individuals treated with CPAP have benefited from remote monitoring. The aim of this study is to assess compliance with CPAP treatment for sleep apnoea and changes in other treatment-related characteristics such as leaks, residual apnoea-hypopnea index etc.

As part of your sleep apnoea treatment, AGIR à dom Assistance, your treatment provider, processes your data to monitor the effects of your treatment and for scientific research purposes.

We must keep your data (in digital format) for 10 years after the end of our service provision. Your data can only be accessed by our teams, who are in charge of your medical and administrative follow-up, and our research partners. All data are pseudonymised, i.e., they contain no information that directly identifies you (such as surname or first name). In accordance with the regulations, your Social Security number will only be communicated to the Social Security System.

Your personal data is processed in accordance with the European Data Protection Regulation (EU Regulation 2016/679 of 27 April 2016). This processing is necessary for reasons of public interest in the field of health.

In this context, AGIR à dom Assistance and Sêmeia, the company in charge of the study, are conducting a study with the following aims:

• The first aim is to identify the determinants of treatment discontinuation and the impact of discontinuation on the occurrence of pathologies and hospitalisations;
• The second aim is to identify the determinants of adherence to treatment, i.e., the number of hours per night of use of continuous positive airway pressure, and the impact of insufficient adherence on the occurrence of pathologies and hospitalisations.

The following pseudonymised data will be used in the study:

• Treatment start date;
• Apnoea/Hypopnoea index at the start of treatment;
• Your weight at the start of treatment and any changes over time;
• Your height;
• Your CPAP treatment mode (auto-titration or fixed);
• The types of interface used with the machine (nasal, facial, nostril) and changes during your treatment;
• The nature and frequency of your service provider’s interventions (visits, calls, etc.);
• The machine(s) used;
• The Apnoea/Hypopnoea index measured each day by the machine;
• The duration of treatment measured each day by the machine;
• The average air pressure measured each day by the machine;
• Air leaks measured each day by the machine.

To enable the study to be carried out, these data will be supplemented by Health Insurance data concerning you, in accordance with the study approval by an independent national scientific committee, the Ethical and Scientific Committee for Research, Studies and Evaluations in the Health Sector (CESREES) and the agreement of the French Data Protection Authority (CNIL). This requires you to provide your Social Security number, which will only be communicated to the Social security system, the trusted third party for this study. AGIR à dom Assistance will not have access to your Health Insurance data and Sêmeia will only have access to your data (in a pseudonymised form) as the party responsible for implementing the study.

In accordance with the French Data Processing and Freedoms Act of 6 January 1978, as amended, you have the right to access, rectify and, if necessary, delete any data concerning you, and the right to object to the processing of such data on legitimate grounds. The request to object to the processing of scientific research must be clearly worded and sent by email to the following address: dpo@agiradom.com or dpo@semeia.io.

If, after contacting us, you believe that your “Data Protection” rights have not been respected, you may submit a complaint to the CNIL.

To find out more, please consult our data protection policy on our website.